#4 – Is biohacking big business?

15. March 2017by ECSA
ECSA News - Is biohacking big business?
eu_logo_ditos

#4 – Is biohacking big business?

Originally published by Pieter van Boheemen here

In this edition, Pieter talks with two people that started their own biotech company: Frederico Muffatto of Digibio and Steven O’Connell of RebelBio, a startup accelerator which focuses on entrepreneurs building technologies in or around the field of Biotech.

 

ECSA

Copyright by European Citizen Science Association (ECSA).
All rights reserved.

Webdesign by Goldweiss

Copyright by European Citizen Science Association (ECSA). All rights reserved.

Webdesign by Goldweiss